Literature DB >> 21317584

Probiotics: the potential for a live microbicide to prevent HIV.

Anke Hemmerling, Craig R Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21317584      PMCID： PMC4422170          DOI： 10.1097/QAI.0b013e3182056ad9

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  10 in total

1.  Understanding perceptions of HIV risk among adolescents in KwaZulu-Natal.

Authors:  Kate Macintyre; Naomi Rutenberg; Lisanne Brown; Ali Karim
Journal:  AIDS Behav       Date:  2004-09

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

Review 3.  Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Gregoria I Betsi; Theodoros Tokas; Stavros Athanasiou
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.

Authors:  Kingsley Anukam; Emmanuel Osazuwa; Ijeoma Ahonkhai; Michael Ngwu; Gibson Osemene; Andrew W Bruce; Gregor Reid
Journal:  Microbes Infect       Date:  2006-03-29       Impact factor: 2.700

5.  AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis.

Authors:  Silvia Caluwaerts; Klaas Vandenbroucke; Lothar Steidler; Sabine Neirynck; Peter Vanhoenacker; Sam Corveleyn; Brynmor Watkins; Stephen Sonis; Bernard Coulie; Pieter Rottiers
Journal:  Oral Oncol       Date:  2010-06-09       Impact factor: 5.337

6.  Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.

Authors:  Rafael C R Martinez; Sílvio A Franceschini; Maristela C Patta; Silvana M Quintana; Bruna C Gomes; Elaine C P De Martinis; Gregor Reid
Journal:  Can J Microbiol       Date:  2009-02       Impact factor: 2.419

7.  Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.

Authors:  P Mastromarino; S Macchia; L Meggiorini; V Trinchieri; L Mosca; M Perluigi; C Midulla
Journal:  Clin Microbiol Infect       Date:  2008-11-22       Impact factor: 8.067

8.  Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice.

Authors:  Klaas Vandenbroucke; Wolfgang Hans; Jacques Van Huysse; Sabine Neirynck; Pieter Demetter; Erik Remaut; Pieter Rottiers; Lothar Steidler
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

9.  Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli.

Authors:  May A D Antonio; Leslie A Meyn; Pamela J Murray; Barbara Busse; Sharon L Hillier
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

10.  Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.

Authors:  Per-Göran Larsson; Babill Stray-Pedersen; Kjeld R Ryttig; Stig Larsen
Journal:  BMC Womens Health       Date:  2008-01-15       Impact factor: 2.809
  10 in total
  3 in total

1.  The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and Lactobacillus colonization.

Authors:  Jennifer E Balkus; Walter Jaoko; Kishorchandra Mandaliya; Barbra A Richardson; Linnet Masese; Ruth Gitau; James Kiarie; Jeanne Marrazzo; Carey Farquhar; R Scott McClelland
Journal:  Sex Transm Dis       Date:  2012-05       Impact factor: 2.830

Review 2.  The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women.

Authors:  Salim S Abdool Karim; Cheryl Baxter; Jo-Ann S Passmore; Lyle R McKinnon; Brent L Williams
Journal:  J Int AIDS Soc       Date:  2019-05       Impact factor: 5.396

3.  Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.

Authors:  Craig R Cohen; Jairam R Lingappa; Jared M Baeten; Musa O Ngayo; Carol A Spiegel; Ting Hong; Deborah Donnell; Connie Celum; Saidi Kapiga; Sinead Delany; Elizabeth A Bukusi
Journal:  PLoS Med       Date:  2012-06-26       Impact factor: 11.069
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.